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Newborn Hearing Screening
Congenital hearing loss affects 2 to 3 per 1000 ba-
bies born in the United States (1,2). In Iowa, this means 
that over 80 babies per year are born deaf or hard-of-
hearing.  Because undetected prelingual hearing loss 
results in childhood speech and language delay and 
because early identification and intervention vastly 
improve outcomes for children, 42 states now have 
legislation that mandates universal newborn hearing 
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screening.  Only 6 of these require written consent of 
parents to perform the screen, which demonstrates 
the establishment of newborn hearing screening as 
a standard of newborn care. Objective, physiological 
hearing screening during the birth admission has been 
endorsed by the American Academy of Pediatrics, the 
Joint Committee on Infant Hearing and government 
health agencies. Prior to the implementation of new-
born hearing screening, the average age of identifica-
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6tion of  congenital hearing loss in the United States was 
2 ½ years (3).  This age of identification has dropped 
dramatically since the achievement of nearly universal 
newborn hearing screening (4).  Along with technologi-
cal advances in hearing aids and cochlear implants, the 
result has been exciting progress in speech, language, 
academic, social and emotional outcomes for children 
who are deaf or hard-of-hearing and their families.
The Iowa EHDI program has benefited from con-
tinuous federal funding from the Centers for Disease 
Control and Prevention and the Bureau of Maternal 
and Child Health. For many years, Iowa had a high 
rate of voluntary screening and Iowa EHDI legislation 
went into effect on January 1, 2004.  Thanks to the ef-
forts of many stakeholders in our hospitals, Area Edu-
cation Agencies (AEAs) and state agencies, the Iowa 
EHDI program can celebrate much success.  By 2007, 
99% of all newborns in Iowa had their hearing screened 
by objective methods during the birth admission.  
Monitoring Infants at Risk for Delayed Onset 
Hearing Loss
Consensus statements about best practices in EHDI 
programs have been periodically published by the 
Joint Committee on Infant Hearing (JCIH) since the 
1960’s.  Joint Committee member organizations in-
clude the American Academy of Audiology, the Amer-
ican Academy of Pediatrics, the American Academy of 
Otolaryngology-Head and Heck Surgery, the Ameri-
can Speech-Language-Hearing Association, and the 
Council on Education of the Deaf.  In their most recent 
statement published in the Fall of 2007 (5), the com-
mittee outlined revised and much improved recom-
mendations for monitoring babies who may pass the 
newborn hearing screen, but are at risk for developing 
delayed onset hearing loss that can also adversely im-
pact speech and language development and social and 
emotional growth.
There are some health conditions or medical history 
factors that put a baby at particular risk for delayed 
onset hearing loss.  Newborn hearing screening will 
detect congenital hearing loss, but by age 4, prevalence 
of permanent childhood hearing loss will grow by 45% 
(6).  These babies will often pass the newborn hearing 
screen, but develop significant permanent hearing loss 
in the first few months or years of life.  Parents and 
primary care providers may even disregard their own 
concerns about hearing because the baby passed the 
newborn screen.  The previous recommendation of the 
JCIH, published in 2000 recommended audiological 
evaluation of babies with any of these risk factors ev-
ery 6 months.  It was quickly recognized that this ap-
proach was neither feasible nor cost-effective.  In their 
2007 position statement, the committee recommended 
that these risk factors be tracked and that babies at 
high risk for developing delayed-onset hearing loss 
receive an audiological evaluation, with the recom-
mended schedule based on the particular risk factor. 
A recent change in Iowa EHDI legislative rules, signed 
by the governor in April 2009, requires reporting of 
these known risk factors into the Iowa EHDI database.
Risk factors for delayed-onset hearing loss that were 
designated by the JCIH are listed in Table 1.  Several of 
these are actually postnatal risk factors, but the com-
mittee included them as a guide for primary care pro-
viders to help decide what children need audiological 
referral, along with on-going medical and speech-lan-
guage surveillance. The committee recommends that 
babies with risk factors should be seen by an audiolo-
gist by 6 months or at least once by 24 to 30 months of 
age (depending on the risk factor) and, of course, soon-
er if hearing loss is suspected or speech or language 
milestones are delayed.  There is some misconception 
that an audiological referral will always result in an 
auditory brainstem response (ABR) test and the cost 
might not be justified.  This is not true.  Although an 
audiological assessment of a young child sometimes 
requires an ABR, audiologists can use other physio-
logical tests and behavioral methods to assess a young 
child’s hearing sensitivity.  
Children who have risk factors that are highly as-
sociated with delayed-onset hearing loss should re-
ceive more frequent audiological assessments. Those 
risk factors that are usually known at birth and are 
highly associated with delayed onset hearing loss are 
family history of permanent childhood hearing loss, 
extracorporeal membrane oxygenation (ECMO), con-
firmed congenital cytomegalovirus infection (CMV) 
and syndromes associated with late onset hearing loss. 
There is a strong relationship between ECMO treat-
ment and sensorineural hearing loss in children, with 
7.5% of ECMO survivors experiencing sensorineural 
hearing loss (7).  This is significantly higher than the 
1-3% of the general NICU population.  Hypoxia or the 
use of associated ototoxic medications are more likely 
the cause of hearing loss than ECMO treatment itself. 
However, the strong correlation has caused the JCIH to 
recommend that ECMO survivors receive close moni-
toring of speech, language and hearing milestones. 
Congenital CMV is also strongly associated with late-
onset hearing loss:  In symptomatic newborns, about 
16% will have congenital hearing loss with 36% having 
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hearing loss by 6 years of age.  In asymptomatic new-
borns, 3% will be born with hearing loss and 11% will 
have permanent hearing loss by age 6 (8). 
The Iowa EHDI Program for Surveillance of 
Children with Risk Factors for Delayed-Onset 
Hearing Loss
The Iowa Early Hearing Detection and Interven-
tion (EHDI) program recently began sending letters to 
families and primary healthcare providers (PCPs) of 
children with risk factors associated with permanent 
hearing loss. The letters provide information about 
recommended follow-up and resources for more in-
formation. We need your help to make this process ef-
ficient and accurate.  Participants in newborn hearing 
screening and follow up can help with this effort in 
many ways:   Please notify families the child has a risk 
factor and explain that a hearing assessment will be 
needed at a later date.  Please mark risk factors in eSP 
(the Iowa EHDI database) records.   Iowa EHDI can 
not notify families and PCPs if they do not know about 
the risk factors.   Please make sure the risk factors are 
correct and confirmed.  Please list the PCP who will see 
the child after discharge from the hospital. 
Table 1: JCIH (2007) Risk factors associated with permanent childhood hearing loss 
(* indicates greater concern for delayed onset hearing loss)
• Caregiver concern* re hearing, speech, language or developmental delay
• Family history* of permanent childhood hearing loss
• NICU stay of >5 days, which may include ECMO* assisted ventilation, exposure to ototoxic medi-
cations (gentamicin and tobramycin) or loop diuretics (furosemide/lasix) and hyperbilirubinemia 
requiring exchange transfusion
• Confirmed in-utero infections, such as CMV*, herpes, rubella, syphilis and toxoplasmosis
• Craniofacial anomalies, including those involving the pinna, ear canal, ear tags, ear pits and tempo-
ral bone anomalies
• Syndromes associated with hearing loss or progressive or late onset hearing loss* such as neurofi-
bromatosis, osteopetrosis and Usher’s syndrome. Other frequent syndromes include Waardenburg, 
Alport, Pendred and Jervell & Lange-Nielson
• Neurodegenerative disorders* such as Hunter syndrome or sensory motor neuropathies, such as 
Friedrich’s ataxia and Charcot-Marie-Tooth syndrome.
• Culture-positive postnatal infections associated with sensorineural hearing loss* including bacterial 
and viral (esp. herpes and varicella) meningitis
• Head trauma esp. basal skull/temporal bone fracture*
• Chemotherapy*
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According to the National Hospital Discharge Survey, the 
overall circumcision rate in the United States in 2006 was 
59.1%.  Rates were highest in the North Central Region, which 
includes Iowa, at 77.9%.  Despite being a rather common pro-
cedure, The American Academy of Pediatrics does not recom-
mend routine neonatal circumcision.  However, parents should 
be provided with accurate and unbiased information in order 
to determine if circumcision is in the best interest of their child. 
There have been numerous studies published regarding pos-
sible medical benefits related to neonatal circumcision.  Evi-
dence suggests a decreased risk of urinary tract infections in 
the first year of life, as well as a decreased risk of penile cancer 
and transmission of sexually transmitted diseases in adult-
hood.  However, the low incidence of urinary tract infections 
and penile cancer in uncircumcised males and the impact of 
condom use on decreasing the risk of STD transmission make 
mandating neonatal circumcision difficult.
If families elect to proceed with circumcision, we must in-
form them the procedure comes with risk, particularly bleed-
ing, infection, and poor cosmetic outcome.  Certainly, one of 
the most common reasons for a circumcision revision is cos-
metic appearance.  Parents should be educated on the subjec-
tive nature of the procedure, particularly regarding the amount 
of foreskin to remove.  It can be difficult to estimate the appro-
priate amount of tissue to remove on an infant penis, because 
the penis will change considerably as the child ages.   This 
means that small differences in foreskin removal at the time 
of circumcision may make big differences in the circumcised 
penis in adulthood.  A consequence of taking off too much skin 
can be pain or skin tearing with erection.  Due to this, most 
clinicians who perform circumcision tend to be more conserva-
tive when deciding how much foreskin to remove.  
Parents should be educated on the typical appearance and 
proper care of the circumcised penis.  A prospective study in 
1997 by Van Howe evaluated the different clinical appearances 
of the circumcised penis.  This study revealed a wide variability 
in the appearance of a penis following circumcision.  Circum-
cised males under the age of 3 years of age were significantly 
more likely to have a partially or completely covered glans. 
However, circumcised males over the age of 3 years were more 
likely to have a fully exposed glans, particularly after reaching 
Tanner Stage V.  These findings suggest that circumcised males 
with redundant foreskin often “grow into” their circumcision, 
and as physicians we should counsel parents against costly 
and unnecessary circumcision revision for cosmetic concerns.   
According to Van Howe, circumcised males less than the 
age of 3 years were also more likely to have a non-cosmetic 
penile problem such as adhesions, skin bridges, trapped epi-
thelial debris, meatitis, preputial stenosis, or balanitis when 
compared to their uncircumcised peers.  Since many of these 
problems are related to hygiene we should counsel parents on 
the proper care of a circumcised penis.  A circumcised male 
needs to have the skin overlying the glans pulled back and 
cleaned regularly until the age of 15-18 months.  This practice 
will assist in preventing the formation of adhesions, skin bridg-
es, and debris accumulation. 
In regards to adhesions, there is some controversy in terms 
of their management.  Certainly, circumcised males with any 
skin overlying the glans are more likely to form adhesions, 
which emphasizes the importance of good hygiene.  The mean 
age for developing adhesions is 6-8 months of age.  Some 
urologists will manually take down adhesions, while others 
feel adhesions can be observed without any intervention, not-
ing that the incidence of adhesions decreases with increasing 
age.  Hypotheses for the natural decrease in adhesions with 
age include nocturnal erections, penile growth, and hormonal 
influences.  Another treatment option for penile adhesions is 
topical betamethasone cream, which has been used as medi-
cal management of phimosis in uncircumcised males for many 
years.   The application of betamethasone cream, 0.05-0.1%, 2-3 
times daily for 3-4 weeks with gentle retraction by the parents 
at home is the approach many general pediatricians recom-
mend.  Palmer et al. published a small study in 2005 which 
showed a success rate of 79% with the use of betamethasone 
cream as treatment for cicatricial scars following circumcision.
In closing, circumcision is an elective procedure with defi-
nite risks and complications.  It is not a procedure to be taken 
lightly and our patients’ families need to be properly educated 
about it.  As physicians it is also important for us to recognize 
normal variants in the circumcised penis, educate our families 
on its proper care, and treat common problems in order to pre-
vent unnecessary referrals and revisions. 
 —Lisa Didion, MD
  Fellow Associate
  University of Iowa Children’s Hospital
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      and Adolescent Medicine
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